ArticleJournal of the American Chemical Society2016

Development of Specific, Irreversible Inhibitors for a Receptor Tyrosine Kinase EphB3.

Alvin Kung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.